Full Schedule
- 12:00 PM - 7:30 PMRegistration, Education and Membership Area Opens
- 1:00 PM - 9:00 PMPre-Courses
- 1:00 PM - 5:30 PMThe ASAM Buprenorphine Course for Office-Based Treatment of Opioid Use DisordersEdwin A. Salsitz, MD, DFASAM – Icahn School of Medicine at Mount Sinai ### 98238###Faculty @@@ R. Corey Waller, MD, MS, FACEP, DFASAM – Spectrum Health Hospitals ### 94977###Faculty
- 6:30 PM - 9:00 PMThe CO*RE/ASAM Opioid Prescribing: Safe Practice, Changing LivesEdwin A. Salsitz, MD, DFASAM – Icahn School of Medicine at Mount Sinai ### 98238###Faculty @@@ R. Corey Waller, MD, MS, FACEP, DFASAM – Spectrum Health Hospitals ### 94977###Faculty
- 9:00 PM - 10:00 PMMutual Help Meeting
- 7:00 AM - 7:45 AMContinental Breakfast
- 7:00 AM - 6:30 PMRegistration, Education and Membership Area Open
- 7:45 AM - 8:00 AMOpening - Day One
- 8:00 AM - 10:00 AMPrescription Opioids: Use, Misuse, Consequences and Countermeasures - Session 1
- 8:00 AM - 8:30 AMThe Epidemiology of Prescription Opioid Abuse and the Recent Transition to HeroinTheodore Cicero, PhD – Washington University School of Medicine in St. Louis ### 219510###Speaker
- 8:30 AM - 9:00 AMCDC Guideline for Prescribing Opioids for Chronic PainDebra Houry, MD, MPH – Centers for Disease Control and Prevention ### 256684###Speaker
- 9:00 AM - 9:30 AMOpioid Therapy for Chronic Pain in the United States: Promises and PerilsMark D. Sullivan, MD, PhD – University of Washington ### 219512###Speaker
- 9:30 AM - 10:00 AMTreating Women for Opioid Use Disorders During Pregnancy: The Latest ResearchHendrée E. Jones, PhD – UNC School of Medicine ### 133421###Author @@@ Karol Kaltenbach, PhD – Jefferson Medical College of Thomas Jefferson University ### 94893###Speaker
- 10:00 AM - 10:30 AMRefreshment Break
- 10:30 AM - 12:45 PMOpioid Use Disorder: Acute and Long Term Treatment Issues - Session 2
- 10:30 AM - 11:00 AMOpioid Agonist Therapy: The Duration DilemmaEdwin A. Salsitz, MD, DFASAM – Icahn School of Medicine at Mount Sinai ### 98238###Speaker
- 11:00 AM - 11:30 AMDuration of Treatment and Tapering Strategies for Opioid Use DisorderEric C. Strain, MD – Johns Hopkins University School of Medicine ### 219514###Speaker
- 11:30 AM - 12:00 PMImplementing Antagonist-Based Relapse Prevention Treatment for Opioid-Dependent IndividualsAdam Bisaga, MD – Columbia University College of Physicians and Surgeons ### 210184###Speaker
- 12:00 PM - 12:30 PMNaloxone for Opioid SafetyPhillip Coffin, MD, MIA – San Francisco Department of Public Health ### 219515###Speaker
- 12:30 PM - 12:45 PMThe Development of an FDA-approved Intranasal Naloxone Product for the Treatment of Opioid OverdosePhil Skolnick, PhD, DSc (Hon.) – National Institute on Drug Abuse, National Institutes of Health ### 241190###Speaker
- 12:45 PM - 1:30 PMLunch - Cash & Go
- 1:30 PM - 3:30 PMHealthcare Delivery: From ACA to Your Practice - Session 3
- 1:30 PM - 2:00 PMUse of CONTINUUM to Meet Federal Health Care ReformsDavid R. Gastfriend, MD, DFASAM – Treatment Research Institute ### 94877###Speaker
- 2:00 PM - 2:30 PMThe Issues and Problems of Performance Standards for Physicians - And What Physicians Need to Do to Thrive in the Next DecadeMichael M. Miller, MD, DFASAM, LFAPA – Rogers Memorial Hospital ### 94922###Speaker
- 2:30 PM - 3:00 PMIssues in Electronic Health Records and 42CFREric Goplerud, PhD, MA – Department on Health Policy, George Washington University Medical Center (GW) ### 94880###Speaker
- 3:00 PM - 3:30 PMPanel DiscussionMichael M. Miller, MD, DFASAM, LFAPA – Rogers Memorial Hospital ### 94922###Speaker @@@ Eric Goplerud, PhD, MA – Department on Health Policy, George Washington University Medical Center (GW) ### 94880###Speaker @@@ David R. Gastfriend, MD, DFASAM – Treatment Research Institute ### 94877###Speaker
- 3:30 PM - 4:00 PMRefreshment Break
- 4:00 PM - 5:30 PMGuidelines for Treating Substance Use Disorders - Session 4
- 4:00 PM - 4:30 PMThe ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid UseKyle M. Kampman, MD – Perelman School of Medicine ### 132093###Speaker
- 4:30 PM - 5:00 PMHHS Opioid InitiativeJennifer Fan, PharmD, JD – Substance Abuse and Mental Health Services Administration ### 219516###Speaker
- 5:00 PM - 5:30 PMGuidelines on Treating Substance Use Disorders During PregnancyHendrée E. Jones, PhD – UNC School of Medicine ### 133421###Author @@@ Karol Kaltenbach, PhD – Jefferson Medical College of Thomas Jefferson University ### 94893###Speaker
- 5:30 PM - 6:30 PMA "Monumental" Reception
- 6:30 PM - 8:00 PMCorporate Roundtable Meeting (By Invitation Only)
- 8:00 PM - 9:00 PMMutual Help Meeting
- 7:00 AM - 8:00 AMContinental Breakfast
- 7:00 AM - 6:30 PMRegistration, Education and Membership Area Open
- 7:45 AM - 8:00 AMOpening - Day Two
- 8:00 AM - 10:00 AMCannabinoids: Therapeutic Potentials and Medical Consequences - Session 5
- 8:00 AM - 8:30 AMCurrent Aspects of Cannabis LegalizationGregory C. Bunt, MD, FASAM – NYU Langone Medical Center ### 94851###Speaker
- 8:30 AM - 9:00 AMHow to Be a Good Doctor in a Political WorldR. Jeffrey Goldsmith, MD, DLFAPA, DFASAM – Professor of Clinical Psychiatry University of Cincinnati College of Medicine ### 192596###Speaker
- 9:00 AM - 9:30 AMThe Evolving Synthetic Cannabis Epidemic: Lessons for PhysiciansRobert L. DuPont, MD – Institute for Behavior and Health, Inc. ### 94865###Speaker
- 9:30 AM - 10:00 AMRole of Cannabinoids in Medicine: Clinical EvidenceJag H. Khalsa, MS, PhD – National Institute on Drug Abuse, NIH ### 130775###Speaker
- 10:00 AM - 10:30 AMRefreshment Break
- 10:30 AM - 12:30 PMWeed in Your Workplace: What You Need To Know - Session 6
- 10:30 AM - 11:00 AMSAMHSA’s Role: Integrating the Science and Technical Information into Regulated TestingRon Flegel, MS – US Department of Health and Human Services ### 219519###Speaker
- 11:00 AM - 11:30 AMThe Changing Landscape of Cannabis Products and How This Impacts Drug Testing ProgramsJohn M. Mitchell, PhD – RTI International ### 219520###Speaker
- 11:30 AM - 12:00 PMThe New Weed Changes the Paradigm and Can Get You into TroubleEdward J. Cone, PhD, FABT – Johns Hopkins University School of Medicine ### 94858###Speaker
- 12:00 PM - 12:30 PMLinking Biomarkers with Behavior: The Complexities of CannabisRyan G. Vandrey, PhD – Johns Hopkins University School of Medicine ### 219522###Speaker
- 12:30 PM - 1:30 PMLunch - Cash & Go
- 1:30 PM - 2:30 PMSpecial Addresses and Open DiscussionGeorge F. Koob, PhD – National Institute on Alcohol Abuse and Alcoholism (NIAAA) ### 143257###Speaker @@@ Wilson M. Compton, MD, MPE – National Institute on Drug Abuse ### 130692###Speaker @@@ Kana Enomoto, MA – Substance Abuse and Mental Health Services Administration ### 247680###Speaker
- 2:30 PM - 3:30 PMNew Issues in Medical Comorbidities - Session 7
- 2:30 PM - 3:00 PMCuring Hepatitis C in Persons Who Inject DrugsDavid L. Thomas, MD, MPH – Johns Hopkins University School of Medicine ### 130776###Speaker
- 3:00 PM - 3:30 PMNeuropsychiatric Complications and Management in HIV/HCV Infected Elderly Substance Abusing PatientsAjay Bharti, MD – University of California San Diego ### 265564###Speaker
- 3:30 PM - 4:00 PMRefreshment Break
- 4:00 PM - 5:30 PMUpdates on Psychiatric Comorbidities - Session 8
- 4:00 PM - 4:30 PMPrevalence and Psychotherapeutic Treatment of PTSD and Substance Use DisordersSudie E. Back, PhD – Medical University of South Carolina ### 219524###Author @@@ Emma L. Barrett, PhD – Medical University of South Carolina ### 256109###Speaker
- 4:30 PM - 5:00 PMNeurobiology and Pharmacologic Treatment of PTSD/SUDThomas Kosten, MD – Baylor College of Medicine ### 94899###Speaker
- 5:00 PM - 5:30 PMCo-occurring Bipolar Disorder, Schizophrenia and Substance Use DisordersE. Sherwood Brown, MD, PhD – The University of Texas Southwestern Medical Center ### 219525###Speaker
- 8:00 PM - 9:00 PMMutual Help Meeting
- 7:00 AM - 8:00 AMContinental Breakfast
- 7:00 AM - 12:00 PMRegistration, Education and Membership Area Open
- 7:45 AM - 8:00 AMOpening - Day Three
- 8:00 AM - 10:00 AMBrain Imaging and Addiction: New Findings - Session 9
- 8:00 AM - 9:00 AMFunctional MRI and Drug Addiction-Current Status and Future PromiseElliot A. Stein, PhD – National Institute on Drug Abuse Intramural Research Program ### 219526###Speaker
- 9:00 AM - 9:30 AMStructural and Functional Correlates of Smoking Cues and Tobacco CravingAmy C. Janes, PhD – McLean Hospital ### 219527###Speaker
- 9:30 AM - 10:00 AMCannabis Abstinence - Relationship to Neural ActivitySarah W. Yip, PhD – Yale School of Medicine ### 219528###Speaker
- 10:00 AM - 10:30 AMRefreshment Break
- 10:30 AM - 12:00 PMNew Pharmacotherapies for Alcohol and Substance Use Disorders - Session 10
- 10:30 AM - 11:00 AMNovel Pharmacological Targets for Treating Alcohol Use DisorderBarbara Mason, PhD – The Scripps Research Institute, La Jolla, CA ### 219529###Speaker
- 11:00 AM - 11:30 AMDeveloping Pharmacological Treatments for Alcohol Use Disorder: Implications for Clinical PracticeLorenzo Leggio, MD, PhD, MSc – Intramural Research Program, NIAAA and NIDA, NIH ### 219530###Speaker
- 11:30 AM - 12:00 PMOpioid Abuse Treatment: New Forms and Delivery Systems for BuprenorphineRichard N. Rosenthal, MD, FASAM – Icahn School of Medicine at Mount Sinai ### 192667###Speaker
- 12:00 PM - 12:30 PMFinal Wrap-Up
Time
Title